Search Results for "Cancer Diagnostics"

00:22 EDT 5th July 2015 | BioPortfolio

Matching Channels

Matching News

Cancer Immunotherapy Meets Companion Diagnostics

In previous notes, I discussed companion diagnostics (see for example: More Details About Roche's Companion Diagnostics Strategy; A Closer Look at Companion Diagnostics Strategies; Some Interesting In...

Global Cancer Diagnostics grants first international license for The Lung Cancer Test to Bertech

Global Cancer Diagnostics announced the signing of a license agreement with Bertech Diagnostics of Edmonton, Alberta.

Prostate Cancer: Dissatisfaction With Current Diagnostics Drives Interest In Innovation

The lack of accurate tools for diagnosing the severity of prostate cancer creates opportunities for start-ups with novel approaches. Profiles of 3D Biopsy, Blue Earth Diagnostics, UroSens, and Prostat...

Laying the Foundation for Next-Gen Cancer Diagnostics

Bio-IT World | This summer, Foundation Medicine will launch what could be described as the next generation of cancer diagnostics. The Cambridge, Mass.-based company, founded by a premier group of can...

Blood Test for Lung Cancer

Molecular diagnostics leader and cancer center's Moon Shots Program launch initiative to identify lung cancer in early stages Exact Sciences Corp. and The University of Texas MD Anderson Cancer Cente...

Miroculus raises $2.3M for low-cost blood test that detects multiple types of cancer

  Diagnostics startup Miroculus became a bit of a media darling last fall, in part from its TED Talk on bringing inexpensive, rapid-fire cancer diagnostics to the developing world. The Bay...

Agendia – decoding cancer

Agendia is a leading molecular diagnostics company developing FFPE-based genomic diagnostic products, allowing clinically relevant gene expression profiling for cancer patients. Agendia – decod...

Start-Up Previews, April 2015

This Month's Profile Group, Prostate Cancer Diagnostics, features profiles of 3DBiopsy, Blue Earth Diagnostics, Prostate Management Diagnostics, and UroSens. Plus these Start-Ups Across Health Care: G...

Matching PubMed Articles

Current situation and challenges in companion diagnostics development.

The personalized health care, it is defined as a medical care which provide the optimal therapy for each individual in consideration of a patient's individual difference, such as a genetic background ...

Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients.

To apply an individualized oncological approach to gastric cancer patients, the accurate diagnosis of disease entities is required. Peritoneal metastasis is the most frequent mode of metastasis in gas...

Gender Differences in Lung Cancer.

More and more women suffer from lung cancer. In comparison to the male patients they are younger and more likely never-smokers. Adenocarcinomas are more frequently in women than in men. Their long-tim...

Reproducible and Reliable Real-time PCR Assay to Measure Mature Form of miR-141.

miR-141 is one of the miRNAs that has significant expression variations in different human malignancies including prostate cancer, hepatocellular carcinoma, renal cell carcinoma, pancreatic cancer, ga...

Combining simple patient-oriented tests with state-of-the-art molecular diagnostics for early diagnosis of cancer.

Early diagnosis is an important strategy to improve outcomes from cancer. Oesophageal adenocarcinoma is an example of a cancer that presents late, with very poor outcomes, and for which the presence o...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement